EcoR1 Capital LLC 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 6:30 pm Sale | 2023-12-31 | 13G | Revolution Medicines, Inc. RVMD | EcoR1 Capital LLC | 132,579 0.100% | -7,066,121 (-98.16%) | Filing |
| 2023-06-16 4:12 pm Purchase | 2023-06-07 | 13G | Revolution Medicines, Inc. RVMD | EcoR1 Capital LLC | 7,198,700 6.800% | 2,720,650 (+60.76%) | Filing |
| 2023-01-23 12:14 pm Purchase | 2023-01-10 | 13G | Revolution Medicines, Inc. RVMD | EcoR1 Capital LLC | 4,478,050 5.000% | 199,981 (+4.67%) | Filing |
| 2022-06-27 4:33 pm Purchase | 2022-06-16 | 13G | Revolution Medicines, Inc. RVMD | EcoR1 Capital LLC | 4,278,069 5.800% | 4,278,069 (New Position) | Filing |